Access barriers to the use of innovative technology such as administrative burden and reimbursement challenges. We will also touch upon payer concern about costs which might be underlying these issues.


  • Barrier to uptake of cell and gene therapies
  • Reimbursement challenges with cell/gene therapies
  • Payer interest in alternative contracts for cell/gene therapies
  • Payer coverage of genetic testing and perception of administrative burden
  • Use and coverage of telemedicine in the wake of COVID-19

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.